Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
H. Lee Moffitt Cancer Center and Research Institute
With
ModernaTX, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At least 18 years of age
Is a cancer patient enrolled in the Cancer Patient Immune Response to COVID-19 Vaccine study (a basic science study) MCC 21138 or who has completed the two mRNA-1273 vaccine series prior to March 31, 2021.
Understands, agrees and is able to comply with the study procedures and provides written informed consent.
Has no known or suspected allergy or history of anaphylaxis, urticaria, or other significant adverse reactions to the vaccine or its excipients.
Has not received more or less than 2 doses of mRNA-1273 vaccine
You may not be if
Participants who will not return for the third vaccine dose
Clareo Health | COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients
